Literature DB >> 19121683

Intensity of exposure and incidence of melioidosis in Thai children.

Allen C Cheng1, Vanaporn Wuthiekanun, Direk Limmathurotsakul, Wirongrong Chierakul, Sharon J Peacock.   

Abstract

There is a high background seroprevalence of antibodies to Burkholderia pseudomallei in Thailand that limits its use as a diagnostic tool. It is believed that this results from childhood exposure to the bacterium in mud and surface water. The increasing prevalence of antibodies with age is a marker of the intensity of exposure. A susceptible-infected-susceptible (SIS) model was calibrated with data on seroprevalence in children (<15 years) in Udon Thani and Ubon Ratchathani (n=2214). In this mathematical model, children were assumed to gain antibodies at a constant rate related to exposure events, and waning antibody response occurred at a constant rate. The intensity of exposure appeared to be higher in Udon Thani than in Ubon Ratchathani, with 24% vs. 11% of patients becoming seropositive each year. In Udon Thani children, antibodies appeared to be long-lasting, compared with those in Ubon Ratchathani, where the mean duration was 5.2 years. Based on an estimated paediatric disease incidence in Ubon Ratchathani of 4.15 per 100,000 population, it is estimated that approximately 1 in 4600 antibody-producing exposures results in clinical infection. Childhood seroprevalence can be used as a marker of intensity of exposure. Further work to separate the effect of exposure to B. thailandensis and cross-reactivity to B. pseudomallei is proposed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19121683     DOI: 10.1016/S0035-9203(08)70010-5

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  15 in total

1.  Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro.

Authors:  Patcharaporn Tippayawat; Maneerat Pinsiri; Darawan Rinchai; Donporn Riyapa; Amornrat Romphruk; Yunn-Hwen Gan; Raymond L Houghton; Philip L Felgner; Richard W Titball; Mark P Stevens; Edouard E Galyov; Gregory J Bancroft; Ganjana Lertmemongkolchai
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

Review 2.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

3.  A prospective study of melioidosis after environmental exposure of healthy participants to Burkholderia pseudomallei during a muddy endurance challenge.

Authors:  Rebecca Grivas; Sarah Barklay; Amber Ruane; Mark Mayo; Vanessa Theobald; Kevin Freeman; Robert Norton; Robert W Baird; Bart J Currie
Journal:  Am J Trop Med Hyg       Date:  2015-01-26       Impact factor: 2.345

4.  Surprisingly low seroprevalence of Burkholderia pseudomallei in exposed healthy adults in the Darwin region of tropical Australia where melioidosis is highly endemic.

Authors:  Gemma L James; Ben Delaney; Linda Ward; Kevin Freeman; Mark Mayo; Bart J Currie
Journal:  Clin Vaccine Immunol       Date:  2013-03-27

5.  High Rates of Premature and Potentially Preventable Death among Patients Surviving Melioidosis in Tropical Australia.

Authors:  Josh Hanson; Simon Smith
Journal:  Am J Trop Med Hyg       Date:  2019-08       Impact factor: 2.345

6.  The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.

Authors:  Bart J Currie; Linda Ward; Allen C Cheng
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

7.  Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models.

Authors:  Direk Limmathurotsakul; Kris Jamsen; Arkhom Arayawichanont; Julie A Simpson; Lisa J White; Sue J Lee; Vanaporn Wuthiekanun; Narisara Chantratita; Allen Cheng; Nicholas P J Day; Claudio Verzilli; Sharon J Peacock
Journal:  PLoS One       Date:  2010-08-30       Impact factor: 3.240

8.  Development of vaccines against burkholderia pseudomallei.

Authors:  Natasha Patel; Laura Conejero; Melanie De Reynal; Anna Easton; Gregory J Bancroft; Richard W Titball
Journal:  Front Microbiol       Date:  2011-09-27       Impact factor: 5.640

9.  Soil characteristics influencing the spatial distribution of melioidosis in Far North Queensland, Australia.

Authors:  I Goodrick; G Todd; J Stewart
Journal:  Epidemiol Infect       Date:  2018-07-04       Impact factor: 4.434

10.  Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis.

Authors:  Raymond L Houghton; Dana E Reed; Mark A Hubbard; Michael J Dillon; Hongjing Chen; Bart J Currie; Mark Mayo; Derek S Sarovich; Vanessa Theobald; Direk Limmathurotsakul; Gumphol Wongsuvan; Narisara Chantratita; Sharon J Peacock; Alex R Hoffmaster; Brea Duval; Paul J Brett; Mary N Burtnick; David P Aucoin
Journal:  PLoS Negl Trop Dis       Date:  2014-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.